| Literature DB >> 29126387 |
Masahiko Murakami1, Koji Otsuka2, Satoru Goto2, Tomotake Ariyoshi2, Takeshi Yamashita2, Takeshi Aoki2.
Abstract
BACKGROUND: The rates of thoracoscopic esophagectomy performed in the prone and left lateral decubitus positions are similar in Japan. We retrospectively reviewed short- and long-term outcomes of thoracoscopic esophagectomy for esophageal cancer performed in the left lateral decubitus position.Entities:
Keywords: Carcinoma of the esophagus; Left lateral decubitus; Thoracoscopy
Mesh:
Year: 2017 PMID: 29126387 PMCID: PMC5681806 DOI: 10.1186/s12885-017-3743-1
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1Port placement: Three 5-mm ports and two 12-mm ports are used
Fig. 2The view after each component of the thoracic dissection. a After dissection of the right recurrent laryngeal nerve lymph nodes: the arrow indicates the right recurrent laryngeal nerve. b After dissection of the left recurrent laryngeal nerve lymph nodes: arrow indicates the cardiac branch of the sympathetic nerve and the arrowhead indicates the left recurrent laryngeal nerve. c After dissection of the subcarinal and main bronchus lymph nodes. d After dissection of lower mediastinal lymph nodes. ESO: esophagus, Crus: crus of the diaphragm, AO: aortic arch
Patient Demographics- all study patients
| All number ( | Early ( | Late ( |
| |
|---|---|---|---|---|
| Age, mean (SD) | 64.9 | 64.9 (9.5) | 66.3 (9.0) | 0.03 |
| Male, n (%) | 539 (82.4) | 239 (82.7) | 300 (82.2) | |
| Tumor location | 0.01 | |||
| Cervical, n (%) | 14 (2.1) | 7 (2.4) | 7 (1.9) | |
| Upper, n (%) | 76 (12) | 40 (14) | 36 (9.9) | |
| Middle, n (%) | 344 (53) | 131 (45) | 213 (58) | |
| Lower, n (%) | 197 (30) | 100 (35) | 97 (27) | |
| Abdominal, n (%) | 23 (3.5) | 11 (3.8) | 12 (3.3) | |
| Histologic findings | 0.05 | |||
| Squamous cell carcinoma, n (%) | 616 (94) | 271 (94) | 345 (95) | |
| Adenocarcinoma, n (%) | 14 (2.1) | 4 (1.4) | 10 (2.7) | |
| Adenosquamous carcinoma, n (%) | 7 (1.1) | 2 (0.7) | 5 (1.4) | |
| Carcinosarcoma, n (%) | 6 (0.9) | 1 (0.3) | 5 (1.4) | |
| Basaloid cell carcinoma, n (%) | 5 (0.8) | 4 (1.4) | 1 (0.3) | |
| Small cell carcinoma, n (%) | 4 (0.6) | 4 (1.4) | 0 (0) | |
| Neuroendocrine cell carcinoma, n (%) | 1 (0.2) | 0 (0) | 1 (0.3) | |
| Malignant melanoma, n (%) | 1 (0.2) | 0 (0) | 1 (0.3) | |
| pTNM Stage | 0.00 | |||
| Stage IA, n (%) | 215 (33) | 68 (24) | 147 (40) | |
| Stage IB, n (%) | 27 (4.1) | 12 (4.2) | 15 (4.1) | |
| Stage IIA, n (%) | 72 (11) | 43 (15) | 29 (7.9) | |
| Stage IIB, n (%) | 73 (11) | 29 (10) | 44 (12) | |
| Stage IIIA, n (%) | 99 (15) | 45 (16) | 54 (15) | |
| Stage IIIB, n (%) | 57 (8.7) | 30 (10) | 27 (7.4) | |
| Stage IIIC, n (%) | 49 (7.5) | 27 (9.3) | 22 (6.0) | |
| Stage IV, n (%) | 62 (9.5) | 35 (12) | 27 (7.4) | |
| Neoadjuvant therapy | <0.001 | |||
| None, n (%) | 185 (28) | 151 (52) | 34 (9.3) | |
| Chemotherapy, n (%) | 337 (52) | 39 (13) | 298 (82) | |
| Chemo-radiation, n (%) | 129 (20) | 97 (34) | 32 (8.8) | |
| Radiation, n (%) | 3 (0.5) | 2 (0.7) | 1 (0.3) | |
| Pleural adhesions | 0.71 | |||
| Yes, n (%) | 206 (32) | 88 (30) | 118 (32) | |
| No, n (%) | 448 (69) | 201 (70) | 247 (68) | |
| Number of Lymphadenectomy Fields | 0.64 | |||
| Two, n (%) | 448 (69) | 201 (70) | 247 (68) | |
| Three, n (%) | 206 (32) | 88 (30) | 118 (32) | |
| Abdominal Procedure | <0.001 | |||
| Hand Assisted Laparoscopic Surgery, n (%) | 558 (85) | 205 (71) | 353 (97) | |
| Laparotomy, n (%) | 96 (15) | 84 (29) | 12 (3.3) | |
| Reconstruction Conduit | 0.01 | |||
| Gastric tube, n (%) | 621 (95) | 272 (94) | 349 (96) | |
| Right colon, n (%) | 22 (3.4) | 7 (2.4) | 15 (4.1) | |
| Jejunum, n (%) | 9 (1.4) | 8 (2.8) | 1 (0.3) | |
| Ileum, n (%) | 2 (0.3) | 2 (0.7) | 0 (0) | |
| Reconstruction Route | 0.01 | |||
| Retrosternal, n (%) | 641 (98) | 280 (97) | 361 (99) | |
| Posterior mediastinal, n (%) | 13 (2.0) | 9 (3.1) | 4 (1.1) | |
| Anastomosis Site | 0.02 | |||
| Cervical, n (%) | 640 (98) | 277 (96) | 363 (99) | |
| Intrathoracic, n (%) | 14 (2.1) | 12 (4.2) | 2 (0.5) | |
| Conversion to thoracotomy, n (%) | 3 (0.5) | 1 (0.3) | 2 (0.5) | 0.70 |
SD: Standard deviation
Surgical Outcomes and Post Operative Complications
| Early (n = 289) | Late (n = 365) |
| |
|---|---|---|---|
| Thoracic operative time (min), mean (SD) | 210.1 (70.4) | 201.1 (64.3) | 0.10 |
| Thoracic blood loss (ml), mean (SD) | 174.0 (285.0) | 94.2 (117.2) | <0.001 |
| Blood transfusion (ml), mean (SD) | 108.7 (1346.8) | 19.0 (204.5) | 0.26 |
| Extubation (days after surgery), mean (SD) | 0.19 (1.04) | 0.16 (1.73) | 0.61 |
| Postoperative length of stay (days), mean (SD) | 33.4 (29.8) | 20.0 (13.1) | <0.001 |
| Number of retrieved thoracic lymph nodes, mean (SD) | 20.0 (13.4) | 28.4 (12.1) | <0.001 |
| Number of retrieved total lymph nodes, mean (SD) | 43.3 (24.3) | 56.1 (24.1) | <0.001 |
| Overall Complications, n (%) | 77 (26.6) | 47 (12.9) | <0.0001 |
| Surgical Complications | |||
| Chylothorax, n (%) | 8 (2.8) | 7 (1.9) | 0.93 |
| Anastomotic leakage, n (%) | 40 (13.9) | 6 (1.6) | <0.0001 |
| Postoperative bleeding, n (%) | 6 (2.1) | 8 (2.2) | 0.92 |
| Recurrent laryngeal nerve paralysis, n (%) | 4 (1.4) | 5 (1.4) | 0.99 |
| Non-Surgical Complications | |||
| Arrhythmia, n (%) | 3 (1.0) | 13 (3.6) | 0.04 |
| Pneumonia, n (%) | 26 (9.0) | 25 (6.8) | 0.24 |
| Reoperation within 30 days, n (%) | 9 (3.1) | 5 (1.4) | 0.13 |
| Mortality within 30 days, n (%) | 4 (1.4) | 0 (0) | 0.02 |
Fig. 3Complications for the two time-periods of the study, Early (left) and Late (right)
Predictors of Overall Complications in late period
| Variables | Odds Ratio | 95% Confidence Interval |
|
|---|---|---|---|
| Age | 1.03 | 0.99–1.08 | 0.09 |
| Neoadjuvant therapy | 1.12 | 0.39–4.13 | 0.83 |
| Abdominal Procedure | 0.24 | 0.04–1.30 | 0.09 |
| Reconstruction Conduit | 0.36 | 0.04–1.96 | 0.27 |
| Reconstruction Route | 1.11 | 0.14–6.83 | 0.35 |
| Anastomosis Site | 6.11 | 0.01–106.2 | 0.72 |
| Thoracic blood loss | 1.00 | 1.00–1.01 | 0.06 |
| Number of retrieved thoracic lymph nodes | 0.97 | 0.93–1.01 | 0.45 |
| Number of retrieved lymph nodes (total) | 1.01 | 0.99–1.03 | 0.45 |
Fig. 4Five-year overall survival for all patients
Fig. 5Five-year survival rate by stage for each of the two study time periods, early (red) and late (blue)
Cox hazard analysis for overall survival
| Variables | Hazard Ratio | 95% Confidence Interval |
|
|---|---|---|---|
| Early | 1.00 | Reference | |
| Late | 1.72 | 1.27–2.32 | 0.00 |
Adjusted to operation time, neo adjuvant therapy (no adjuvant therapy vs. any adjuvant therapy), blood transfusion (no blood transfusion vs. blood transfusion), complications (no complications vs. any complications)